Morgan Stanley
CVRX icon

Morgan Stanley’s CVRx CVRX Stock Holding History

Morgan Stanley’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$745K Buy
144,977
+5,613
+4% +$36.2K ﹤0.01% 5365
2026
Q1 		$1.32M Sell
139,364
-241,277
-63% -$1.77M ﹤0.01% 5008
2025
Q4 		$2.7M Sell
380,641
-50,910
-12% -$465K ﹤0.01% 4603
2025
Q3 		$3.48M Buy
431,551
+63,300
+17% +$476K ﹤0.01% 4424
2025
Q2 		$2.17M Buy
368,251
+169,246
+85% +$1.17M ﹤0.01% 4648
2025
Q1 		$2.43M Sell
199,005
-16,130
-7% -$228K ﹤0.01% 4479
2024
Q4 		$2.73M Sell
215,135
-16,149
-7% -$199K ﹤0.01% 4472
2024
Q3 		$2.04M Buy
231,284
+39,876
+21% +$363K ﹤0.01% 4636
2024
Q2 		$2.29M Sell
191,408
-11,408
-6% -$131K ﹤0.01% 4471
2024
Q1 		$3.69M Buy
202,816
+93,176
+85% +$2.21M ﹤0.01% 4159
2023
Q4 		$3.45M Buy
109,640
+50,946
+87% +$956K ﹤0.01% 4173
2023
Q3 		$890K Sell
58,694
-3,874
-6% -$63.7K ﹤0.01% 4868
2023
Q2 		$966K Sell
62,568
-8,559
-12% -$104K ﹤0.01% 4853
2023
Q1 		$663K Buy
71,127
+56,179
+376% +$743K ﹤0.01% 5094
2022
Q4 		$274K Buy
14,948
+5,816
+64% +$71.8K ﹤0.01% 5538
2022
Q3 		$85K Sell
9,132
-14,188
-61% -$112K ﹤0.01% 6159
2022
Q2 		$141K Sell
23,320
-14,185
-38% -$81.6K ﹤0.01% 6082
2022
Q1 		$224K Buy
37,505
+27,614
+279% +$223K ﹤0.01% 5858
2021
Q4 		$122K Sell
9,891
-284
-3% -$4.12K ﹤0.01% 6320
2021
Q3 		$169K Buy
+10,175
New +$195K ﹤0.01% 6089

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley's CVRX Position: Q2 2026 in Review

Morgan Stanley increased its CVRx (CVRX) stake by 4% in Q2 2026, buying an estimated $36.2K and bringing the position to 144,977 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #5365.

Morgan Stanley first reported a position in CVRX in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.69M in Q1 2024. 87 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

  • Morgan Stanley held 144,977 shares of CVRx worth $745K as of Q2 2026.
  • Morgan Stanley bought 5,613 CVRx shares in Q2 2026, an estimated $36.2K.
  • CVRx made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5365 holding.
  • Morgan Stanley first reported a position in CVRx in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's CVRx position peaked at $3.69M in Q1 2024.
  • 87 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.